Literature DB >> 16488891

SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux.

Tamara A Pagler1, Sebastian Rhode, Angelika Neuhofer, Hildegard Laggner, Wolfgang Strobl, Claudia Hinterndorfer, Ivo Volf, Margit Pavelka, Erik R M Eckhardt, Deneys R van der Westhuyzen, Gerhard J Schütz, Herbert Stangl.   

Abstract

The high density lipoprotein (HDL) receptor, scavenger receptor class B, type I (SR-BI), mediates selective cholesteryl ester uptake from lipoproteins into liver and steroidogenic tissues but also cholesterol efflux from macrophages to HDL. Recently, we demonstrated the uptake of HDL particles in SR-BI overexpressing Chinese hamster ovarian cells (ldlA7-SRBI) using ultrasensitive microscopy. In this study we show that this uptake of entire HDL particles is followed by resecretion. After uptake, HDL is localized in endocytic vesicles and organelles en route to the perinuclear area; many HDL-positive compartments were classified as multivesiculated and multilamellated organelles by electron microscopy. By using 125I-labeled HDL, we found that approximately 0.8% of the HDL added to the media is taken up by the ldlA7-SRBI cells within 1 h, and almost all HDL is finally resecreted. 125I-Labeled low density lipoprotein showed a very similar association, uptake, and resecretion pattern in ldlA7-SRBI cells that do not express any low density lipoprotein receptor. Moreover, we demonstrate that the process of HDL cell association, uptake, and resecretion occurs in three physiologically relevant cell systems, the liver cell line HepG2, the adrenal cell line Y1BS1, and phorbol myristate acetate-differentiated THP-1 cells as a model for macrophages. Finally, we present evidence that HDL retroendocytosis represents one of the pathways for cholesterol efflux.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488891     DOI: 10.1074/jbc.M510261200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

2.  The ins and outs of lipid efflux.

Authors:  Stefan Lorkowski
Journal:  J Mol Med (Berl)       Date:  2008-02       Impact factor: 4.599

Review 3.  The macular carotenoids: A biochemical overview.

Authors:  Ranganathan Arunkumar; Aruna Gorusupudi; Paul S Bernstein
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-10       Impact factor: 4.698

4.  Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.

Authors:  Ricquita D Pollard; Christopher N Blesso; Manal Zabalawi; Brian Fulp; Mark Gerelus; Xuewei Zhu; Erica W Lyons; Nebil Nuradin; Omar L Francone; Xiang-An Li; Daisy Sahoo; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

5.  Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles.

Authors:  Qiaoya Lin; Juan Chen; Kenneth K Ng; Weiguo Cao; Zhihong Zhang; Gang Zheng
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

6.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Salman Azhar
Journal:  Nutr Metab (Lond)       Date:  2010-06-01       Impact factor: 4.169

7.  An induction in hepatic HDL secretion associated with reduced ATPase expression.

Authors:  Nihar R Pandey; Joanna Renwick; Seham Rabaa; Ayesha Misquith; Lara Kouri; Erin Twomey; Daniel L Sparks
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

8.  High-Density Lipoproteins for Therapeutic Delivery Systems.

Authors:  R Kannan Mutharasan; Linda Foit; C Shad Thaxton
Journal:  J Mater Chem B       Date:  2015-11-24       Impact factor: 6.331

9.  A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis.

Authors:  Susan M Armstrong; Michael G Sugiyama; Karen Y Y Fung; Yizhuo Gao; Changsen Wang; Andrew S Levy; Paymon Azizi; Mark Roufaiel; Su-Ning Zhu; Dante Neculai; Charles Yin; Steffen-Sebastian Bolz; Nabil G Seidah; Myron I Cybulsky; Bryan Heit; Warren L Lee
Journal:  Cardiovasc Res       Date:  2015-09-02       Impact factor: 10.787

10.  Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity.

Authors:  Thomas J F Nieland; Jared T Shaw; Firoz A Jaipuri; Jay L Duffner; Angela N Koehler; Sotirios Banakos; Vassilis I Zannis; Tomas Kirchhausen; Monty Krieger
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.